Weiss Asset reports 11.1M Avadel (NASDAQ: AVDL) shares on Form 3
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Avadel Pharmaceuticals received a Form 3 indicating that Weiss Asset Management LP and Andrew Weiss are reporting as ten percent owners. The filing shows indirect beneficial ownership of 11,112,052 ordinary shares, held by two private investment funds managed by Weiss Asset Management. The reporting parties and related entities disclaim beneficial ownership except for their pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Weiss Asset Management LP, WEISS ANDREW M
Role
10% Owner | 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 11,112,052 shares (Indirect, See Footnote 1)
Footnotes (1)
- [object Object]
FAQ
What does the Weiss Asset Management Form 3 for AVDL disclose?
The Form 3 discloses that Weiss Asset Management LP and Andrew Weiss are ten percent owners of Avadel Pharmaceuticals, reporting indirect beneficial ownership of 11,112,052 ordinary shares held through two private investment funds managed by Weiss Asset Management LP.
Is the Avadel (AVDL) Form 3 a buy or sell transaction?
This Form 3 does not report a buy or sell transaction. It is an initial ownership statement showing existing indirect beneficial ownership of 11,112,052 Avadel ordinary shares, rather than a new purchase or sale in the market.